This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Merck Serono S. a.. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: Marco Muda: Innovator in Folliculogenesis Research
Introduction
Marco Muda is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of reproductive medicine through his innovative research and patents. With a total of 2 patents, Muda is recognized for his work on follicle-stimulating hormone (FSH) mutants.
Latest Patents
Muda's latest patents include the FSH glycosylation variant D3N, which is an FSH mutant characterized by increased glycosylation and a longer half-life. This invention describes the use of this FSH mutant for inducing folliculogenesis in human patients. Additionally, he has developed FSH mutants that also exhibit increased glycosylation and longer half-lives, further detailing their application in promoting folliculogenesis in human patients.
Career Highlights
Marco Muda is currently employed at Merck Serono S. A., where he continues to advance his research in reproductive health. His work has the potential to significantly impact fertility treatments and improve outcomes for patients seeking assistance with reproductive challenges.
Collaborations
Muda collaborates with esteemed colleagues, including Xuliang Jiang and Sean D McKenna, to enhance the scope and impact of his research.
Conclusion
Marco Muda's innovative work in the field of reproductive medicine, particularly through his patents on FSH mutants, showcases his commitment to advancing healthcare solutions. His contributions are poised to make a lasting impact on fertility treatments and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile